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Abstract
Susceptibility to infection by the intracellular bacterial pathogen, Salmonella
enterica serovar Typhimurium (S. typhimurium), is controlled by many genes of
innate and adaptive immunity. One of the most critical genes is IFN- and mice
deficient in IFN- synthesis are highly susceptible to Salmonella. Previously, we
demonstrated that mice deficient in MyD88, an adaptor that regulates TLR signaling,
are susceptible to Salmonella infection. In the current study, we compared immune
responses in mice deficient in IFN- or MyD88 with wild-type controls following
infection with an attenuated strain of S. typhimurium (designated BRD509E) or a
recombinant derivative engineered to express murine IFN- (GIDIFN). Infection
studies with BRD509E or GIDIFN revealed that the latter strain was significantly
less virulent in immunodeficient mice than BRD509E and correlated with decreased
bacterial loads in systemic organs. Enhanced responsiveness was due to GIDIFN
strain’s ability to activate effector macrophages, as shown by increased synthesis of
inflammatory cytokines and anti-microbial effector molecules, including NO. Gene
expression profiling by qPCR demonstrated stronger induction of key inflammatory
modulators by GIDIFN in macrophages of immunodeficient animals. These findings
suggest that immunotherapeutic approaches using attenuated bacterial strains
expressing immunomodulatory genes is more efficacious and offers a superior safety
profile even in severely immunodeficient hosts.
Keywords:
IFNInnate immunity; Salmonella infection.
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)Title and Abstract (in Arabic

تحريض اإلستجابات المناعية المضادة للميكروبات في نموذج حيواني منقوص
المناعة ,عند تعرضه لبكتيريا السالمونيال المنتجة لإلنتفيرون جاما ) .(IFN-هذه
اإلستجابة مرتبطة بتفعيل كفاءة الخاليا البلعومية ). (Macrophages
قابلية اإلصابة من قبل بكتيريا السالمونيال التيفية الفأرية (،)S. typhimuriumتعتمد على العديد
من جينات المناعة الفطرية والتكيفية .واحد من الجينات األكثر أهمية هو  IFN-والفئران الغير
قابلة النتاج  IFN-هم عرضة لإلصابة ببكتيريا السالمونيال .في السابق أثبتنا أن الفئران
منقوصة  ،MyD88و هو محول ينظم إشارات مستقبل الخلية ) ،)TLRهم أيضا معرضون
لإلصابة بنفس الجرثومة .في الدراسة الحالية قارنا االستجابات المناعية في الفئران ذوات نقص
في  IFN-أو  MyD88مع نوع مضعف من ساللة بكتيريا السالمونيال التيفية الفأرية (تسمى
)BRD509أو نوع آخر مشتق من الساللة السابقة مدعمة جينيا إلنتاج ( IFN-تسمى
.(GIDIFNو كشفت النتائج أن إصابة الفئران ذوات النقص في  IFN-بالبكتيريا القابلة النتاج
 IFN-كانت أقل ضررا من النوع اآلخر ،و قد كان مرتبطا بانخفاض في أعداد البكتيريا
المتواجدة في األعضاء الداخلية للفئران .وقد ربطت هذه النتائج بسبب قدرة ساللة GIDIFN
على تفعيل الخاليا البلعومية ( )Macrophagesمن خالل زيادة إفراز افرازالسيتوكينات
االلتهابية ( )Inflammatory cytokinesوالجزيئات المضادة للميكروبات ،بما في ذلك
النيتريك أوكسيد ) .(NOتشير دراسة التعبير الجيني ( )qPCRأثبت أن الخاليا البلعومية
( )Macrophagesلديها إستجابة أقوى لبكتيريا GIDIFN -من خالل تحويل نشاط هذه
الخاليا بصورة أقوى إلى تفاعل مضاد للجراثيم في الفئران ذوات النقص في الجهاز المناعي.
وتشير هذه النتائج إلى أن النهج باستخدام هذه الساللة من البكتيريا القابلة على تغيير نمط
اإلستجابة المناعية للمرضى الذين يعانون من نقص في الجهاز المناعي تعطي نتائج أكثر كفاءة
و سالمة.
الكلمات المفتاحية:
اإلنتفيرون جاما ،المناعة الفطرية ،مرض السالمونيال
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Chapter 1: Introduction
Salmonella is an intra-macrophage pathogen that is transmitted through the
oral route, causing a localized gastroenteritis, or a systemic typhoid fever or
bacteremia. Salmonella colonizes the macrophages, and replicates inside the socalled Salmonella containing vacuole (SCV). This capacity is regulated by the
Salmonella pathogenicity island (SPI), an important virulence factor. Immunity to
Salmonella is dependent on IFN-, a cytokine with powerful macrophage-activating
properties that acts to induce their microbicidal potential. Moreover, IFN-functions
to shift the antibody response to Th1-mediated isotypes, which includes IgG2a and
IgG3, which are critical for enhanced bacterial opsonization and phagocytosis as well
as antibody-dependent cellular cytotoxicity (ADCC). Proper development of a Th1
cell-mediated immune response and production of appropriate antibodies are
required for the efficient control of primary Salmonella infections.

1.1. Classification of Salmonella

Salmonella are facultative intracellular bacteria that belong to the
Enterobacteriaceae family, a group that contains other gram-negative, medically
important bacteria like Shigella and E. coli. The Salmonella’s genus consists of two
species, S. enterica and S. bongori, the latter being an opportunistic pathogen and
restricted to cold blooded animals (Euzéby, 1999), making the other genus (S.
enterica) of most interest in the study of host-parasite interactions.
S. enterica is divided into six subspecies and is further classified to
serogroups based on their somatic (O) and flagellar (H) antigens (Costa et al., 2012).
These subspecies are genetically similar but can be classified according to their host
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tropism and whether they cause systemic or local infections. S. enterica serovar
Typhi is a human pathogen that results in systemic infection (typhoid fever) and does
not naturally, infect any other mammals. S. enterica serovar Typhimurium, causes a
systemic infection (typhoid like disease) in mice, and a localized gastroenteritis in
humans (Parry et al., 2002). Other serovars of these subspecies are also hostrestricted, such as S. Dublin in bovine and S. Cholerasuis in swine (Costa et al.,
2012).
Salmonella-mediated infections have a global impact. In developed nations,
gastroenteritis caused by Non-Typhoidal Salmonella (NTS) is a major cause of
mortality due to contaminated food, with food outbreaks having a significant impact
on the healthcare system and economy of affected countries (Nyachuba, 2010). On
the other hand, Salmonella has a greater impact on the developing nations of the
globe. Salmonella Typhi and Paratyphi strains are transmitted from human to human
due to lack of proper sanitation system and poor hygiene, resulting in systemic
infections with high mortality rates (Parry et al., 2002). Moreover, in immunedeficient individuals (such as HIV patients), infections by NTS are associated with
high death rates due to the rapid and systemic dissemination of the pathogens
(Feasey et al., 2012).

1.2. Salmonella pathogenesis

Studying the pathogenesis of Salmonella requires the availability of an
animal model that mimics the interactions occurring in humans. S. Typhi and S.
Paratyphi are both human-restricted serovars that cause a systemic infection, called
typhoid fever. These serovars are not pathogenic in animals; instead serovar S.
typimurium is capable of infecting mice, causing an invasive systemic typhoid-like
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disease, making it the most widely accepted model of typhoid fever in experimental
animals (Hormaeche, 1979).
Salmonella bacteria encode many virulence factors that facilitate their
efficient invasion in host tissue. Being a water-borne pathogen, the primary mode of
transmission is through the oral route. After colonizing the lumen of the intestine
(Fig. 1), the bacteria start producing molecules that are injected to the epithelia lining
of the mucosa in a needle like projection called type III secretion system (T3SS).
This invasion machinery is regulated by genes located in a genetic locus called
Salmonella pathogenicity island 1 (SPI-1). It has been shown that mutations in SPI-1
render Salmonella non-virulent (Penheiter et al., 1997). Consequent to the invasion,
Salmonella organisms colonize host macrophages and use them for intracellular
replication as well as for systemic dissemination to target organs. This phase of
infection is regulated by a set of proteins encoded on SPI-2 (Salmonella
pathogenicity island 2) (Salcedo et al., 2001). Upon entry into host macrophages,
Salmonella organisms are taken up into a phagosome that fuses with the lysosome to
form a phagolysosome, enabling the lysis of the invading bacteria (Chakravortty et
al., 2002). Host macrophages also play an important role as antigen-presenting cells,
displaying Salmonella-derived peptides with MHC class II molecules for recognition
by CD4+ T cells, thereby initiating the adaptive immune response (Mittrücker et al.,
2002).
In case of Salmonella, induction of the SPI-2 encoded type III secretion
system prevents the fusion of the lysosome with the phagosome, thus acting as a
critical virulence factor (Cirillo et al. 1998; Pfeifer et al. 1999). The action of SPI-2encoded proteins transforms the phagosome into a hospitable environment, named
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Figure 1: Salmonella pathogenesis.
Schematic illustration of the infection of epithelial cells of the lower intestine
and macrophages by Salmonella is shown (A) Salmonella then translocate across
M cells of Peyer’s patches or actively invade epithelial cells by the secretion of
effector proteins through the SPI-1 encoded T3SS-1.(B) (i) After crossing the
epithelial barrier, Salmonella are engulfed by proximal macrophages that will
secrete effector proteins into the cytosol of the cell via the SPI-2 encoded T3SS2 and prevent fusion of the phagosome with the lysosome. (ii)With in the SCV,
Salmonella will proliferate resulting in cytokine secretion by the macrophage.
(iii) Finally, the macrophage will undergo apoptosis, and Salmonella will escape
the cell to basolaterally reinvade epithelial cells or other phagocytic cells of the
host innate immune system. (Reference: Hurley et al., 2014).

Salmonella-containing vacuole (SCV), which allows bacterial replication and growth
(Lefebre & Galán et al., 2014). Recently, another study challenged these earlier
findings by demonstrating that high bacterial loads can be achieved within
phagocytic cells by SPI-2 mutant bacterial strains (Grant et al., 2012). Instead, the
new data favor a model whereby SPI-2 T3SS confers the ability on the bacteria to
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exit the infected macrophage and establish new foci of infection, thereby aiding in
bacterial dissemination. The induction of SPI-2 effectors during the acute phase of
the infection is a critical determinant of Salmonella virulence and its capacity to
spread systemically into deeper host tissues. Salmonella strains carrying mutations in
SPI-2 fail to cause a systemic infection (Penheiter et al., 1997).

1.3. Innate immunity to Salmonella infection

Salmonella infection occurs through the ingestion of contaminated
food/water, in which Salmonella survive the stomach acidity and colonizes the
intestine (Muller et al., 2009). Invasion of the intestinal epithelium is facilitated
through specialized cells called M cells (Microfold cells) which functions by
sampling the antigenic contents of the gut (Halle et al., 2007) This process is
dependent on the SPI-1 which encodes several proteins that are injected through a
needle-like complex called T3SS (type 3 secretory system). These proteins hijack the
cell machinery in order to facilitate the bacterial invasion process (Jones et al., 1994;
Penheiter et al., 1997). Once the bacterium reaches the lymphoid cells in Peyer’s
patches (PP), it gets engulfed by the phagocytes located there (Hopkins et al., 2000;
Wick, 2002). Meanwhile, macrophage containing bacteria travel through the body’s
lymphatic system to the mesenteric lymph node (MLN) and then the bacteria at that
stage starts spreading systemically to the spleen and liver ( Mittrücker & Kaufmann
et al., 2000).
Control of the salmonella infection is mediated by the host’s different
components of the innate immune system components, which must prevent the
systemic spread of bacteria (Fig. 2). Early recognition of Salmonella bacteria is
mediated by the TLRs (Toll like receptors), a family of pattern recognition receptors
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(PRRs), that recognize conserved components of Salmonella called pathogen
associated molecular patterns (PAMP). To date, four TLRs have been shown to be
involved in the response to Salmonella infection, including TLR2, TLR4, TLR5 and
TLR9 which mediate the recognition of lipoproteins and bacterial amyloid fibers,
lipopolysaccharide, flagellin, and CpG DNA, respectively (Takeuchi et al., 1999;
Gewirtz et al., 2001; Feuillet et al., 2006; O'Brien et al., 1980; Vazquez-Torres et al.,
2004; Hayashi et al., 2001; Tükel et al, 2009). Additionally, a different family of
intracellular receptors, called NOD-like receptors (NLRs), mediates the recognition
of Salmonella virulence protein products (Miao et al., 2010). Recognition of multiple
bacterial products via PRRs results in the production of proinflammatory cytokines
and chemokines, which, in turn, leads to the recruitment of neutrophils and
monocytes to the site of recognition (intestinal lymphoid tissue). Migration of these
cells forms an inflammatory foci, and results in increasing the level of TNF-, IL-1
and nitric oxide that will arrest bacterial spread (Rydström & Wick, 2007). The
inflammatory foci will lead to the production of other inflammatory cytokines such
as IL-6, IL-12, IL-18 and IL-23 (Thiennimitr et al., 2012). That will have an impact
on lymphocytes and NK cells, inducing the production of IFN-. IFN- activates the
microbicidal activity of the phagocyte-containing bacteria, as well as the activation
of a CD4+ Th1 immune response that contributes to the complete clearance of the
bacterium, and provides the host with protection against secondary infection through
the adaptive immune response (Hormaeche et al., 1990).
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Figure 2: Innate immunity to intracellular pathogens.
A schematic presentation of the innate immune response, CD4+ T cell
differentiation and function of major regulatory cytokines generated in response
to infection with intracellular pathogens. Effector Th1 CD4+ T cells, CD8+ T
cells, and NK cells activate the phagocytes, through IFN-γ production, to kill the
intracellular microbes via generation of toxic products such as NO and ROIs.
(Reference: Ismail et al., 2002).

1.4. Animal models for Salmonella infection

Studying the mechanisms of a particular pathogen requires the availability of
model that mimics the events occurring in humans. As previously stated, oral
inoculation of S. typhimurium causes a systemic infection in mice similar to typhoid
fever in humans, making it a suitable typhoid fever model (Hormaeche, 1979) . The
genetic makeup of the host is decisive in determining the susceptibility to infection.
By gene targeting several mouse models have been developed to study the role of
different genes in Salmonella infection. Using a virulent strain of bacteria in a
susceptible mouse background, leads to early mortality. In contrast, the use of
attenuated strains of Salmonella allows one to dissect the complex interplay between
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pathogen and host. The derivation of Salmonella strains carrying mutations in
various genes of the metabolic pathway has greatly facilitated work on defining the
contribution of various host genes in Salmonella infection. The best characterized
Salmonella mutants have genetic mutations in genes coding for enzymes involved in
the biosynthetic pathway of aromatic amino acids, such as aminobenzoic acid and
dihydroxybenzoic acid. As these aromatic compounds are not normally produced in
mammalian hosts, the use of bacterial strains with these genetic mutations render
them avirulent (Hoiseth & Stocker 1981).

1.5. Susceptibility factors to salmonella infection

Immunity to Salmonella infection requires the synergistic effect of multiple
components of the immune system. Defects in specific immune system pathways
increase the host’s susceptibility to Salmonella infection. The use of attenuated
Salmonella strains and genetically defined animal models have greatly facilitated
work on dissecting the contribution of different components of the immune system.
In this section, the role of the most important contributing factors in Salmonella
infection will be discussed.

1.5.1. Nramp1

Studies have identified a gene that controls bacterial replication, as an innate
resistance trait for Salmonella infection, called Nramp1 gene (Natural resistance
associated macrophage protein1) (Vidal et al., 1995). The Nramp1 gene encodes a
transmembrane lysosomal protein that acts as a channel for divalent cations and
controls intracellular microbial replication during the early phase of infection. The
Nramp1-associated resistance to infection is due to an almost complete inhibition of
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early bacterial growth in phagocytic cells (Plant & Glynn, 1979; Gruenheid & Gros,
2000; Forbes and Gros 2001).
Nramp1 is considered a resistance factor in Salmonella infection and
functions at multiple levels to enhance the macrophage killing ability: 1) increases
response to activating cytokines TNF- and IFN-, 2) enhances antigen processing
and presentation by increasing the expression of MHC class II molecule to facilitate
the CD4+ T-cell expansion, and 3) increase the early production of IFN- by NK cells
(Soo et al., 1998). Certain inbred mouse strains, such as C57BL/6 and BALB/c, carry
a mutated form of the Nramp1 gene and are at least 1000-fold more susceptible to
infection with S. typhimurium than 129sv and C3H lineage mouse strains that carry
the wild-type gene allele. Mutations in Nramp1 gene have also been associated with
increased susceptibility to intracellular infections in humans (Skamene et al. 1998).

1.5.2. Toll like receptors

TLRs play an essential role in the innate immune response against Salmonella
infection. C3H/HeJ mice are well known for their hyporesponsiveness to LPS and for
being hypersusceptible to Gram-negative bacterial infections (O’Brien et al., 1982).
The underlying genetic basis of this phenotype was shown to be a mutation in the
TLR4 gene (Poltorak et al., 1998; Qureshi et al., 1999), which emphasizes the central
role of LPS recognition by TLR4 in the immune response to Salmonella infection.
As referred to earlier, other Salmonella PAMPs known to be recognized by TLRs
include lipoprotein (TLR2), flagellin (TLR5) and CpG DNA (TLR9). Among those
receptors, TLR4 appears to be the most crucial in immunity to Salmonella due to its
effect on secreting proinflammatory cytokines upon recognition of Salmonella,
which leads to macrophage activation and killing of the bacteria by the activation of
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antimicrobial effectors such as nitric oxide (Weiss et al., 2004) . Despite the fact that
C3H/HeJ mice harbor a functional Nramp1 gene, infection with an attenuated strain
of S. typhimurium revealed a defect in controlling the growth of the bacteria when
compared to mice harboring functional TLR4 gene, supporting the essential role of
TLR4 in immunity to Salmonella infections ( Al-Ojali et al., 2013).

1.5.3. MyD88

Myeloid differentiation protein-88 (MyD88) is an adaptor molecule for
utilizing the TLR signals upon the recognition of pathogens. MyD88 recruits IL-1
receptor-associated kinase 4 (IRAK4) and TNF receptor-activated factor 6 (TRAF6),
which leads to the activation of NF-b, and eventually the expression of
proinflammatory cytokines and chemokines. It has been shown that MyD88
deficiency leads to losing the protective immunity to pyogenic bacteria in humans
and animals (von Bernuth et al., 2008). Furthermore, mice lacking MyD88 are highly
susceptible to attenuated strain of S. typhimurium due to their inability to control
systemic bacterial spread and growth in target organs, accompanied with delayed
recruitment of phagocytic cells, and defective cytokine production (Issac et al.,
2013).

1.5.4. Cytokines

Communication between immune cells is accomplished through cytokines
that act on cells harboring cytokine-specific receptors and causing a particular
response through the signal transduction machinery. Immunity to Salmonella
infection requires the collaboration between multiple cytokines to drive the immune
cells to the proper action and, eventually, control the infection. To date, many studies
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in the Salmonella model have highlighted critical roles for TNF-, IL-12, IL-18 and
IFN- in Salmonella immunity. Defects in any of these cytokines or their receptors
increase the host’s susceptibility to Salmonella infection.

1.5.4.1. TNF-

Tumor necrosis factor alpha (TNF-) is an inflammatory cytokine that has an
essential role in controlling infection of different pathogens (Mastroeni et al., 1992;
Green et al., 1993). It is associated with the recruitment of mononuclear cells and
induction of nitric oxide that lead to bacterial killing (Havell, 1989; Mastroeni et al.,
1995). TNF- works synergistically with IFN- to enhance the bactericidal activity
of macrophages (Tite et al., 1991). A previous study has shown that mice with
defects in TNF- receptor expression have heightened susceptibility to virulent as
well as avirulent strains of S. typhimurium in an oral infection model (Everest et al.,
1998). Interestingly, these mice appeared to be less prone to infection-related
mortality by attenuated aroA- Salmonella mutants in comparison with mice deficient
in IFN- (Hess et al., 1996).
Another study investigated the precise role of TNF- in macrophage
phagocytic and anti-Salmonella microbicidal activity (Vázquez-Torres et al., 2001)
and demonstrated that TNFRp55-deficient macrophages are unable to localize
NADPH oxidase-containing vesicles to Salmonella-containing vacuoles, resulting in
increased susceptibility to infection.
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1.5.4.2. IL-12

Interleukin 12 (IL-12) is a heterodimeric cytokine produced primarily by
macrophages, polymorphonuclear cells and dendritic cells following engagement of
PRRs by PAMPs (Brunda, 1994). IL-12 mediates immunity to Salmonella through
the induction of IFN- production by NK cells and T cells, and facilitates the
development of a Th1 response (Castro et al., 1995; Manetti et al., 1993). Resistance
to many intracellular pathogens, such as Leishmania, Mycobacterium and Brucella,
is mediated by IL-12 (Locksley, 1993; Cooper et al., 1995; Heinzel et al., 1995; Zhan
& Cheers, 1995).
In innately resistance A/J mice (normal Nramp1n), neutralization of IL-12 via
monoclonal antibodies, impaired the control of bacterial proliferation at late stage of
infection with virulent S. Typhimurium C5 strain. This effect correlated with a
significant decrease in IFN- levels in serum and spleen when compared with nontreated infected mice (Mastroeni et al., 1996).
Neutralization of IL-12 in susceptible BALB/c mice (mutated Nramp1d gene)
exacerbated infection with an attenuated aroA-deficient strain of S. typhimurium,
with a significant increase in the bacterial burden in the spleen and liver 100-fold
more than non-treated infected BALB/c. The increased susceptibility was mediated
through a reduction in IFN- and downregulation of the expression of MHC class II
and iNOS, important indicators of deficient macrophage activation. Treatment of
these mice with recombinant IFN- restored their host resistance, reduced bacterial
burden in spleen and liver, up-regulated MHC class II in macrophages and decreased
the level of IL-10 which was elevated when treated with anti-IL-12. The results from
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this study demonstrate the protective role of IL-12 in host defense against Salmonella
infection, which is mediated by IFN- (Mastroeni et al., 1998).

1.5.4.3. IL-18

Interleukin-18 (IL-18) is a cytokine produced by several cell types in
response to bacterial and inflammatory stimuli (Stoll et al., 1997). IL-18 works
synergistically with IL-12 to promote the production of IFN- from T-cells, in part
by IL-12-mediated induction of IL-18 receptor expression (Takeda et al., 1998). This
cytokine plays an important role in defense against Salmonella bacteria, as
neutralization using monoclonal antibodies lead to an increase in bacterial load in
spleen and liver, coinciding with low IFN- levels in serum. Treatment of these mice
with recombinant IL-18, reversed the neutralization effect and increased mice
survival and IFN- production (Mastroeni et al., 1999). Finally, IL-18 is dependent
on the availability of IL-12 in order to induce IFN-production, which was
confirmed by failure of treating infected IL-12p40 knockout mice with recombinant
IL-18, to increase the production of IFN- necessary for enhancing the survival of
these mice (Dybing et al., 1999).

1.5.4.4. IFN-

Interferons were first discovered as physiologic agents that interfere with
viral replication (Isaacs & Lindenmann, 1957). They are classified into type I
(consisting of IFN IFNIFN and IFNand type II which only consist of
IFN IFNis structurally unrelated to type I interferons, and binds to a specific
receptor composed of two subunits (IFN-R1 and IFN-R2).
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Signaling through the IFN- receptor is mediated by JAK1 and JAK2, two
Janus tyrosine Kinases that transmit the signal through phosphorylation of STAT1
(signal transducer and activator of transcription) (Schindler et al., 2007).
Phosphorylation of STAT1 allows dimerization of the molecule allowing it to
translocate to the nucleus and act as a transcription factor responsible for the upregulation of many IFN- regulated genes (Bach et al., 1997).
IFN- is produced in response to a microbial encounter in a temporal fashion.
Depending on the phase of the immune response, two cell types are primarily
responsible for IFN- production. NK cells are the main producers during the early
innate phase of the immune response and CD4+ Th1 cells during the adaptive
immune response phase. The whole process begins by the recognition of a pathogen
associated molecular pattern (PAMP), such as lipopolysaccharide (LPS), by a pattern
recognition receptor (PRR) on macrophages and dendritic cells. This engagement
triggers a cascade of downstream signaling pathway, which is crucially dependent on
the adaptor molecule MyD88 (Myeloid Differentiation 88), ultimately leading to the
activation of the transcription factor NF-b. As a master regulator, NF-b activates
gene transcription of many proinflammatory cytokines, including IL-1, IL-6, IL-12,
IL-18 and TNF-. IL-12 plays a critical dual role in activating NK cells to produce
IFN- and induces the differentiation of CD4+ T cells to the Th1 pathway (Xie et al.,
1997; Schwacha et al., 1998). The secreted IFN-, in turn, binds to its high-affinity
receptors on macrophages leading to increased macrophage microbicidal activity
and, hence, elimination of the invading pathogen (Mastroeni et al., 1998; Mastroeni
et al., 1999; Pie et al., 1997).
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1.6. Adaptive immunity to Salmonella infection

Controlling Salmonella infection at early stages is maintained by the innate
immune system. However, achieving full protection and complete eradication of
Salmonella at later stages of infection requires the development of a Salmonellaspecific T cell response.
In primary infections with attenuated Salmonella strains in susceptible mice,
CD4+ TCR+ T cells with a Th1 phenotype mediate the clearance of the bacteria
from the tissues with little or no obvious contribution of CD8+ T cells (Hess et al.,
1996). B cells are dispensable in primary infection with similar attenuated
Salmonella strains, as mice lacking B cells were able to resolve infection with similar
kinetics to wild type mice (Mcsorley et al., 2000; Mastroeni et al., 2000).
On the other hand, resistance to virulent challenge in susceptible mice
requires the action of both CD4+ and CD8+ T cells with the additional requirement
for anti-Salmonella antibodies (Mastroeni et al., 1992; Mastroeni et al., 1993). In
these studies, depletion of CD4+ or CD8+ T cells in mice immunized with attenuated
Salmonella strain, leads to the death of mice after challenge with virulent strain of
Salmonella (Mastroeni et al., 1992), and the adoptive transfer of spleen cells alone
from immunized to naïve mice was not sufficient for conferring protection against
virulent Salmonella infection (Mastroeni et al., 1993). However, the transfer of
spleen cells and serum was shown to provide immunity against challenge with
virulent Salmonella infection (Mastroeni et al., 1993).
CD4+ T cells contribute to protection via the production of Th1 cytokines
such as IFN-and TNF-that leads to the activation of macrophages containing
Salmonella (Ravindran et al., 2005). Depletion of Th1 cytokines (IFN-, TNF- and
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IL-12) impaired the protection of immunized mice after secondary infection with
Salmonella ((Mastroeni et al., 1998; Mastroeni et al., 1992).
CD8+ T cells are important for host defense against intracellular pathogens
(Kaufmann et al., 1995). They kill Salmonella-infected host target cells via the
release of cytotoxins (perforin 1 and granzymes), creating holes in the target-cells
membrane (Harty & Bevan, 1999).
B cells have an essential role in providing protection against virulent
Salmonella infection, since B cells-deficient mice challenged orally with virulent
Salmonella after vaccination, failed to control the infection (Mastroeni et al., 2000).
In addition, B cells also confer protection through its contribution in the expansion of
anti-Salmonella Th1 cells. This was observed in a study, where total splenocytes and
purified CD4+ T cells isolated from Igh-6-/- (B cell deficient) mice after vaccination
showed an impaired production of Th1 cytokines after stimulation in vitro with
Salmonella antigens (Ugrinovic et al., 2003).

1.7. Role of IFN- in immunity to Salmonella

IFN- is a decisive factor in immunity to Salmonella infection. The essential
function of IFN- is to activate macrophages and yield a protective response by
enhancing antigen presentation, and skewing the T-cells towards a protective Th1
response (Shtrichman & Samuel, 2001). In innately resistant mice, depletion of IFN with mAbs resulted in the loss of resistance to a virulent strain of S. typhimurium,
and mice succumb to infection at early stage of infection (7 days), in comparison to
the non-treated infected mice where they remained alive through the infection course
(Nauciel & Espinasse-Maes, 1992). In susceptible C57BL/6 mice (mutated Nramp1),
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oral infection with attenuated aroA-/aroD- mutants S. typhimurium, resulted in a
controlled infection with all mice surviving the infection. This was attributed
primarily to IFN-, as infecting IFN--deficient mice with same bacterial dose
rendered them susceptible to an attenuated strain of Salmonella. This susceptibility
was marked with increased bacterial growth over time seen as lesions in liver, spleen,
mesenteric lymph node and PP, as compared to a controlled bacterial growth in wild
type mice. Histological analysis, showed a decrease in the cells expressing MHC
class II, suggesting a defect in macrophage activation (Bao et al., 2000). This IFN-
dependent expression of MHC class II was observed in another study where Bacillus
Calmette Guerin (BCG) infection in IFN- knockout mice, also showed susceptibility
related to the lack of macrophage activation, impaired nitric oxide production and
reduced MHC class II expression (Dalton et al., 1993).

1.8. Role of IFN- in Salmonella persistence

In human Salmonella infection, about (1-6%) of the patients become chronic
carriers, with bacteria remaining in these patients without causing any symptoms, but
showing a continuous bacterial shedding in stool and urine for a long period of time
that ranged from 1 year to lifetime (Levine et al., 1982). This occurs despite evidence
of adequate immune responses in these carriers, including high levels of serum
antibodies against the pathogen (House et al., 2001). A similar phenomenon was
observed in inherently-resistant mice, such as strain 129sv with functional Nramp1,
infected orally with virulent S. typhimurium (strain SL1344). In this model, mice
were infected and monitored for up to one year for bacterial shedding in the feces
(Monack et al., 2004). The findings showed that infection resulted in bacterial
persistence and fecal shedding throughout the study period. This occurred despite
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evidence of high levels of anti-Salmonella antibodies being present in infected mice.
Examination of the systemic colonization of bacteria over the 1-year period
identified the mesenteric lymph nodes as the site where bacteria persisted. Since
many studies have shown the role of IFN- in maintaining the early phase of
Salmonella infection (Nauciel & Espinasse-Maes, 1992), the role of IFN- in
Salmonella persistence was studied. Depletion of IFN- in chronically infected mice
(260 days post infection) by a 3-week treatment with a neutralizing mAb led to the
systemic spread of bacteria to different organs. This confirmed the primary role of
IFN- in maintaining the balance between the immune system and bacteria, by
suppressing bacterial replication in infected macrophages (Monack et al., 2004).

1.9. Recombinant attenuated Salmonella

Attenuated strains of Salmonella had been greatly used in humans as vector
encoded vaccines for a variety of non-Salmonella pathogens. This effect was
attributed to invasive characteristics of Salmonella that elucidate B and T cell
memory response with long lasting immunity (Roland & Brenneman, 2013).
Attenuated Salmonella strains have been used for vaccine delivery through cloning
genes encoding heterologous protective antigens, and then the Salmonella express
that antigen through a stable Inducible promoter. Attenuated Salmonella has been
used in one study as a vaccine for Leishmania major parasite, where attenuated
Salmonella expressing GP63 afforded protection to susceptible BALB/c mice after
oral challenge with virulent Leishmania. This protection was developed through a
Th1 response and yielded a high levels of Leishmania-specific antibodies (Xu et al.,
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1995). Other studies have used attenuated Salmonella engineered to express
heterologous proteins of other pathogens, including viruses, bacteria and fungi.
These strains were able to achieve specific immune response and render protection
upon challenge with virulent pathogen (Pasetti et al., 2003).

1.10.

Attenuated Salmonella expressing cytokines

The use of attenuated Salmonella as vaccine is effective when the
circumstances of achieving a specific immune response towards the vaccine are met.
The fate of such vaccine requires the availability of a healthy immune response.
However, using an attenuated vaccine in immunocompromized hosts could lead to
systemic, lethal, infections. An attenuated strain of Salmonella engineered to express
a particular cytokine is one way of guiding the immune response of
immunocompromized hosts to achieve the required protection.
This was first done with the construction of an attenuated strain of
Salmonella that expressed the human IL-1 cytokine. The resultant strain was able to
cause an immunological reaction influenced by the expressed cytokine, shown by the
high levels of antibodies against the engineered human IL-1 (Carrier et al., 1992).
This was followed by the construction of attenuated Salmonella strains
expressing murine cytokines, including IL-2, TNF-, IFN- and MIF (Xu et al.,
1998). These strains were used to boost the immunity of susceptible BALB/c mice
against Leishmania major infection through the induction of protective Th1
responses (Xu et al., 1998). The potential of these cytokine-expressing strains in
regulating anti-Salmonella immune responses in susceptible BALB/c mice was also
explored (al-Ramadi et al., 2001; al-Ramadi et al., 2002). Salmonella strains
expressing IL-2 or TNF-, designated GIDIL2 and GIDTNF respectively, were
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compared with parental non cytokine-expressing Salmonella strain, designated
BRD509E, in terms of their influence on the anti-Salmonella immune response. The
findings demonstrated that the expression of IL-2 by the GIDIL2 strain led to a rapid
clearance of bacteria with decreased splenomegaly and enhanced macrophage
activation through the upregulation of cell surface proteins and induction of high
levels of nitric oxide synthesis. GIDIL2-vaccinated mice also developed high levels
of resistance to subsequent challenge with the virulent SL1344 Salmonella strain (alRamadi et al., 2001; al-Ramadi et al., 2002).
Subsequent studies focused on analyzing the effect of infection with
cytokine-expressing strains in immunodeficient mice with the aim of delivering
compensatory tools for different immunodeficient mouse model. Given the essential
role of IFN- in immunity against Salmonella, an attenuated strain of Salmonella was
engineered to express murine IFN-, designated GIDIFN (Xu et al., 1998). In vitro
studies have shown the ability of GIDIFN to induce a strong immune response
demonstrated by the production of TNF-, IL-6, IL-12p40 and NO, with specific
targeting of macrophages leading to the upregulation of several activation markers
and surface costimulatory molecules. These effects were much more pronounced
than with the use of GIDIL2 or the parental, non-cytokine-expressing, BRD509E
strain (Fernandez-Cabezudo et al., 2009). Furthermore, the potential of GIDIFN was
tested in vivo in different immunocompromized murine models. GIDIFN was able to
confer a protective response to mice with a deficiency in TLR4, an essential
molecule for the recognition of LPS component of the bacteria (Al-Ojali et al.,
2013). This effect correlated with a more efficient control of bacterial proliferation in
systemic target organs, presumably through the increased production of
proinflammatory cytokines IL-6 and IL-12 (Al-Ojali et al., 2013). Vaccination of
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these susceptible mice with GIDIFN also provided protection against challenge with
virulent Salmonella that was significantly higher than in mice immunized with
BRD509 (Al-Ojali et al., 2013). GIDIFN was also able to enhance the anti-bacterial
response in mice deficient in CD154 protein, an essential molecule for induction of
type 1 cytokines and antibody isotype switching response (al-Ramadi et al., 2006;
Al-Ojali et al., 2012). This was demonstrated by reduced bacterial load in target
organs and increased mouse survival, which was mechanistically linked with an
enhanced proinflammatory cytokine response, including IL-6, IL-12, TNF- and
IFN- (Al-Ojali et al., 2012). In addition, GIDIFN was able to afford protection to
CD154-/- mice when challenged with lethal Salmonella (Al-Ojali et al., 2012).
A previous study demonstrated that mice deficient in IFN- regained their
resistance after injecting them with recombinant IFN- (Mastroeni et al., 1998). So
we hypothesized that it might be possible to compensate for the deficiency of IFN-
in IFN- mice through the use of the GIDIFN Salmonella strain. This is the
premise on which the studies conducted in this project were carried out.
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Chapter 2: Materials and Methods
2.1 Materials
2.1.1. Summary of materials used and suppliers
Materials

Company

SS Agar

Mast Group

Ampicillin

Sigma

Streptomycin

Sigma

Microscopic slides

Fischer Scientific

7-AAD Viability Staining Solution

e-Bioscience

PBS (-CaCL2 – MgCl2 )

GIBCO

BSA

Sigma

RPMI 1640 medium (-L glutamine)

HyClone

Ethanol

Carlo Erba

H2SO4

Readel-de Haen

Trypan blue solution (0.4%)

Sigma

Thioglycolate

Sigma-Aldrich

Trypticase soy broth

Oxoid

24 well tissue culture plates

Becton Dickenson

96 well Microtest U bottom culture
plates

Becton Dickenson

96 well Maxisorp Nunc Immuno plate

Thermo Scientific

Table 1: Summary of materials used and supplies
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2.1.2. Summary of antibodies used
Antibody

Conjugate

Company

Catalogue

Dilution
used

Armenian
hamster antimouse CD3

FITC

e-Bioscience

11-0031-85

1:100

Rat anti-mouse
CD11b

APCeFluor780

e-Bioscience

47-0112-82

1:500

Rat anti-mouse
CD19

PE-cy7

BD Pharmingen

552854

1:200

Rat anti-mouse
Gr-1

PE

BD Pharmingen

553128

1:500

Armenian
Hamster IgG1
Isotype Control

Alexa
Fluor488

e-Bioscience

12488883

1:200

Rat IgG2b,k
Isotype Control

APCeFluor780

e-Bioscience

47-4031-82

1:200

Rat IgG2a,k
Isotype Control

PE-cy7

e-Bioscience

25-4321-82

1:200

Rat IgG2b,k
Isotype Control

PE

e-Bioscience

12-4031-82

1:200

Anti-mouse
CD16/CD32

-

e-Bioscience

14-0161-85

1:100

Table 2: Summary of antibodies used
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2.1.3. List of primers used for RT-PCR

Gene

Source

Assay I.D

Reporter

Quencher

dye
HPRT

Applied biosystem

Mm01545399-ml

FAM

NFQ

iNOS

Applied biosystem

Mm00440502-m1

FAM

NFQ

S100A9

Applied biosystem

Mm00656925-m1

FAM

NFQ

Table 3: Summary of primers used for RT-PCR

2.1.4. Mice

C57BL/6 mice were purchased from Harlan Olac (Bicester, UK). All strains
were bred at the animal facility in the College of Medicine and Health Sciences,
UAE University and used at 8–12 weeks of age. Mice received rodent chow and
water ad libitum. All studies involving animals were carried out in accordance with,
and after approval of, the animal research ethics committee of the College of
Medicine and Health Sciences, UAE University.

2.2. Methods

2.2.1. Bacterial strains and growth condtions
BRD509E is an attenuated, aroA−/aroD− mutant strain derived from SL1344
with an LD50 of 5 x106 CFUs per mouse when administered i.p. to susceptible mice.
For the current study, a derivative of BRD509E expressing the empty nirB plasmid
vector, which was developed in al-Ramadi laboratory, was used. The latter strain
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behaves indistinguishably from BRD509E except for the fact that it acquired
resistance to ampicllin, which is encoded by the nirB plasmid, and can, therefore, be
easily selected, transfectant of the BRD509E strain, designated GIDIFN, in which
the murine IFN- gene is expressed, was also used. The expression of IFN- is under
the control of the anaerobic growth-induced nirB promoter, and cytokine expression
was maintained by selection in 100 μg/ml ampicilin.
Aliquots of frozen bacteria were routinely plated on Salmonella Shigella
(S.S) agar (Oxoid, Basingstoke, United Kingdom) in the presence of ampicillin and
grown overnight at 37°C. Five to ten CFUs were cultured overnight in Trypticase
Soy broth and then diluted 1:10 in fresh medium and grown for a further 2-3 hr at 37
°C with shaking. For induction of cytokine expression, bacterial colonies of the
GIDIFN strain were grown under anaerobic conditions overnight at 37°C in T-Soy
broth containing ampicillin and 4 mg/ml glucose in a closed screw-cap container.
The concentration of bacterial suspensions was estimated from spectrophotometer
readings at 600nm wavelength using the following formula:
OD600 of 0.1 =1.2x108 CFUs/ml

Appropriate dilutions of log-phase bacterial suspensions were prepared in
pyrogen-free phosphorus-buffered saline (PBS) (Sigma Chemical Co., St. Louis,
Mo.) and administered i.p. in 0.5 ml volume per mouse. Bacterial doses were
confirmed by CFU plate counts.

2.2.2. Enumeration of bacteria in organ homogenates

To determine liver bacterial load, the organs were removed aseptically,
individually weighed and homogenized in 1 ml of cold sterile saline in an Ultra-
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terrax T25 tissue homogeniser (Janke and Kunkle, Staufenim Breisgau, Germany). A
100 μl aliquot of the homogenate, or an appropriate dilution, was plated on SS agar
plates in the presence or absence of ampicillin, and viable CFUs were determined
after an overnight incubation.

2.2.3. Peritoneal cells preparation

Thioglycolate (4%) was injected to groups of mice 3 days before processing
day. After sacrificing mouse,10 ml of cold Ca2+, Mg2+ free physiological saline was
injected into the exposed peritoneal cavity. Peritoneal fluid obtained from individual
mice was withdrawn through the anterior abdominal wall with a 20-gauge needle.
Then cells were spun down at 1200 rpm for 5 minutes at 4oC. Cells were counted on
a hemocytometer and cell viability was determined by trypan blue dye.

2.2.4. Spleen cell preparation

Single cell suspensions were prepared by gently teasing the spleen between
frosted ends of microscope slides. Cells were spun down at 1200rpm for 5 minutes at
4oC. The spleen cell suspension was depleted of red blood cells by incubation in
RBC lysis buffer (8.3NH4Cl, 1g KHCO3 1.3ml of 5%EDTA dissolved in 1L distilled
water) (4 ml/spleen + 6 ml of PBS) for 5 minutes, after which they were spun down
at 1200 rpm for 5 minutes and suspended in 1xPBS. Cells were counted on a
hemocytometer and cell viability was determined by trypan blue dye.

2.2.5. Peritoneal cell culture

Peritoneal cells from thioglycolate-injected mice were harvested and pooled
from several similarly-treated mice per group. Cells were seeded in 24-well plates
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(2x106 cells/well) in 5% antibiotic-free RPMI medium and incubated for 2 hours at
37oC. Log phase BRD509 or GIDIFN were prepared at different MOIs. Cells were
incubated with bacteria for 1 hour to allow bacterial invasion, after which cells were
treated with 200 g/ml of gentamicin for 30 minutes to kill all remaining
extracellular bacteria. Then medium was replaced with a fresh medium containing 20
g/ml of gentamicin, and cells were incubated for 4 hours, and cell-free supernatants
were collected and kept at -20°C. Trizol (0.5 ml) was added to the cells in each well
collected and stored at -80°C for RNA extraction.

2.2.6. Nitric oxide determination
Production of NO was measured by the accumulation of NO2- in culture
supernatants using the Griess reaction. Cells were cultured under the indicated
conditions for 4 hours and then cell-free culture supernatants were collected and
frozen at -20°C until analysed. Nitrite content was determined by mixing 50µl of
culture supernatant with an equal volume of Griess reagent (0.05% N-1napthylethylenediamide hydrochloride, 0.5% sulphanilamide in 2.5 % phosphoric
acid) and incubated at room temperature for 5 to 10 minutes. Nitrite concentration
was quantified using NaNO2 as the standard and expressed as the micromolar
concentration of NO2- per 2×106 PECs after 4 hours of incubation. The absorbance at
562 nm was measured in an automated microplate reader.

2.2.7. Flow cytometry

Spleen or peritoneal cell suspensions were prepared from normal or infected
mice. Cells were re-suspended in staining buffer (PBS/1% FCS/0.1% NaN3) at a
concentration of 0.5 x 106 cells/well in U-bottom 96-well plate (BD) and incubated
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with 50 l/well of anti-mouse CD16/CD32-specific mAB (clone 2.4G2) for 30
minutes at 4oC to block FcRIII/II sites in order to avoid nonspecific binding. The
plate was then centrifuged at 750 rpm for 3 minutes at 4oC. After decanting the
buffer, cells were stained with appropriate dilutions, as mentioned in directly
conjugated monoclonal antibodies (mAbs; all purchased from eBioscience or BD or
Biolegend) in a total volume of 100 l/well and analyzed by 6-color FACS. In all
staining groups, 7-AAD dye (eBioscience) was included in order to exclude nonviable cells from the analysis. All antibodies were pre-titrated in preliminary
experiments and used at saturating concentrations. Cells were incubated with a
mixture of appropriately diluted mAbs at 4oC for 30 minutes followed by two wash
cycles with staining buffer. The first wash was with 100 l/well of staining buffer
where the cells were mixed well with the pipette and centrifuged. In the second
wash, 200l/well of staining buffer was added and mixed well followed by
centrifugation. Cells were finally re-suspended in 200 l/well of staining buffer. Data
was collected on 30,000 cells using BD FACSCantoII and analyzed by BD
FACSDiva software. Gating strategies is shown in Fig.3. First, we exclude dead cells
by gating on the 7AAD negative cells (P2 gate) (Fig.3 A). Then, we analyzed the
immunophenotype of these viable cells based on the expression of different cell
markers (Fig.3 B).
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Figure 3: Flow cytometric analysis gating strategies.
Illustration of the gating strategies for flow cytometric analysis. (A) Dot plot
showing SSC vs. 7AAD staining. Gate P2 indicates viable (7AAD-negative) cells.
(B) Immunophenotyping of viable PECs based on the expression of different cell
surface markers (CD11b, Gr-1, and CD19).

2.2.8. RNA extraction using Trizol

RNA was extracted from peritoneal cells by the Trizol method. Cells (2-5 x
106 per sample) were pelleted and re-suspended in 1 ml Trizol (Invitrogen) following
which 200l of chlorophorm was added and mixed well. Once cells were spun down
at 14000 rpm for 10 minutes, 3 phases are obtained from which the top clear RNA
layer (~500l) was transferred to a new tube. Equal volume of 2-propanol (~500l)
was then added and mixed well to precipitate the RNA. Tubes were spun again,
supernatant was discarded and 500l of 70% ethanol added. On flicking the tubes,
RNA was observed as a white pellet. Tubes were spun again, supernatant removed
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and RNA was finally suspended in 20-40l nuclease free water and stored in -800C.
The quality and quantity of RNA was determined using the Nanodrop ND-1000
spectrophotometer (Thermo Scientific, Waltham, MA).

2.2.9. Reverse Transcription Reaction

RNA was reverse transcribed using TaqMan reverse transcription reagent
(Applied Biosystem #N8080234). Each master mix reaction contained 10x RT
buffer, 25mM MgCl2, deoxy NTPs mixture (2.5mM), random hexamers
(50RNAase inhibitor (20U/l) and MultiScribe RT enzyme. The master mix
was aliquoted into separate PCR tubes. RNA was added (1g/10l per reaction) and
total volume was made up to 50l with nuclease-free water. The one step RT-PCR
reaction was on GeneAmp PCR System 2700 (Applied Biosystem), under the
following conditions: hexamer incubation for 10 minutes at 250C, reverse
transcription at 480C for 30 minutes and reverse transcription inactivation at 950C for
5 minutes. The samples were held at 40C for a maximum for 1 hour until the sample
could be removed and stored at –200C.

2.2.10. Real time PCR reactions

The real time PCR was performed using TaqMan gene expression assay as
specified below and amplified using the 7500 Real Time PCR System (Applied
Biosystems). Each 20l PCR reaction contained 10l of 2xTaqMan Universal
Master Mix (Applied Biosystems #4440047), 1l of 20x TaqMan assays Mix
(Applied Biosystems #4331182), 2l cDNA and 7l nuclease-free water. A
negative PCR reaction was also carried out using only the reaction mixture without
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cDNA in order to ensure that there was no DNA contamination. The thermal cycling
conditions were as follows: 950C for 10 minutes (Inactivation of Reverse
Transcriptase and activation of TaqMan polymerase), 950C for 15 seconds
(denaturation of dsDNA) and 600C for 1 minute (annealing/extension-fluorescent
data collected during this step) for a total of 40 cycles with the threshold set as 0.2.
Data was analyzed using the Ct values for each sample that were in duplicates.
Results were normalized to HRPT (Hypoxanthine-guanine phosphoribosyl
transferase) and the mRNA fold change was determined using the following
equation:
Fold change= 2[Ct (infected)]/2[Ct (control)],
where Ct (infected) = threshold cycle (Ct) for target gene after infection – Ct for
HPRT after infection and Ct(control) = Ct for target gene saline treated – Ct for
HPRT saline treated.

The control used was uninfected wild-type (C57BL/6).

2.2.11. Statistical Analysis

Statistical significance was analyzed using Student's unpaired t-test, Mannwhitney test, or one way ANOVA with Tukey’s multiple comparison test using the
statistical program of GraphPad Prism software (San Diego, CA). Differences
between experimental groups were considered significant when p values were <0.05.
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Chapter 3: Results
3.1. Susceptibility to infection by attenuated Salmonella

Differential susceptibility of immunodeficient mice to Salmonella infection
normally involves an intricate interplay between cells as well as soluble factors of the
innate and adaptive immune systems (al-Ramadi et al., 2006). Given the facultative
intracellular growth nature of the pathogen, macrophages and Th1 lymphocytes play
critical roles in host protection. One of the most important Th1-produced cytokines
for macrophage activation is IFN-. Importantly, this proinflammatory cytokine
upregulates anti-microbial (microbicidal) activity of host macrophages through
induction of different effectors, such as ROS and NO. Moreover, the induction of the
T lymphocyte differentiation pathway towards Th1 cells is dependent on IL-12, a
product secreted primarily by macrophages following stimulation by microbial
ligands through TLRs. Most TLR signaling pathways depend on MyD88 adaptor
protein for functionality, hence this molecule’s central importance in innate immune
responses. It is clear, therefore, that both innate and adaptive immune systems
cooperate in the response to Salmonella infection.
To assess the importance of various components of the immune system in
Salmonella infection, two genetically modified mouse strains were used; the first
with a deficiency in MyD88 expression, referred to as MyD88-/- (Adachi et al., 1998)
and the second carrying a deficiency in IFN- synthesis, IFN-/-. Using an attenuated,
double auxotrophic, strain of S. typhimurium, designated BRD509E (al-Ramadi et
al., 2001; al-Ramadi et al., 2004), we compared the course of infection in wild type
control (C57BL/6 mice) and the two immunodeficient mouse strains. The LD50 of
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BRD509E in wild-type mice is >2x106/mouse when given i.p. (al-Ramadi et al.,
2006). For the current study, the bacterial dose used for infection ranged from 300 to
1000 CFUs per mouse and the host survival data for the three mouse strains is
illustrated in Figure 4. As expected, no infection-related mortality was observed in
C57BL/6 mice. However, MyD88-/- mice infected with BRD509E exhibited an
overall survival of 35% over the 60-day observation period. This suggests that the
LD50 dose is <1 x 103 per mouse, representing ~2000-fold increase in susceptibility
to infection compared to wild-type mice. A similar dose BRD509E inoculation in
IFN-/- mice was associated with a significantly higher mortality with 100% of the
mice succumbing to infection by day 28 (p < 0.0001). Median survival of BRD509infected MyD88-/- and IFN-/- mice was 51 days and 19.5 days, respectively (Fig. 4).
Next, we assessed the differential susceptibility of MyD88-/- and IFN-/- mice
to infection by a genetically-engineered transfectant of BRD509 in which murine
IFN- is expressed under the control of a prokaryotic promoter (strain GIDIFN) (Xu,
et al. 1998). Using a similar dose to BRD509E (verified dose was 300 CFUs/animal),
infection with the GIDIFN strain resulted in markedly decreased mortality in both
immunodeficient mouse strains (Fig. 4). For MyD88-/- mice, 90% of animals
survived the infection with GIDIFN in contrast to the 35% of mice that survived after
BRD509 inoculation (p = 0.0003). In further studies, increasing the dose of GIDIFN
to 1x105 CFUs/mouse led to 60% overall survival (Al-Ojali S. and al-Ramadi BK,
unpublished data), suggesting that the LD50 for GIDIFN in MyD88-/- mice was
>1x105 CFUs/mouse, which represents >300-fold increase in resistance to infection
compared to the BRD509E Salmonella strain.
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An essentially similar picture emerged when IFN-/- mice were infected with
the GIDIFN bacterial strain (Fig. 4). The right-sided shift observed in the survival
curve signifies decreased mortality in GIDIFN-infected mice in comparison to those
infected with BRD509E (p <0.0001). Despite the increase in mean survival from
19.5 to 26.5 days in animals injected with GIDIFN, the level of resistance to
Salmonella infection did not match what was observed in similarly treated MyD88-/mice. It is therefore clear that notwithstanding the fact that IFN-/- mice are
significantly more susceptible to Salmonella infection than MyD88-/- mice, infection
with a strain of bacteria expressing the immunoregulatory cytokine IFN led to a
marked decrease in the level of susceptibility to Salmonella infection.

Figure 4: Relative survival of WT vs. MyD88-/- vs. IFN-/- deficient mice
following infection with BRD509E or GIDIFN Salmonella strain.
WT and MyD88-/- were infected with 103 CFUs/mouse, while IFN-/- were infected
with 300 CFUs/mouse. Survival was scored for up to 60 days after inoculation.
Asterisks denote statistically significant differences between BRD509E and
GIDIFN-infected mice (*p ≤0.05, **p ≤0.01, ***p ≤0.0001). The results are
representative of 6 independent experiments.
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3.2. Bacterial loads in systemic organs
We next assessed the extent of bacterial loads in target organs in different
strains of mice following infection with BRD509E or GIDIFN. The data for MyD88/-

vs. WT mice comparison is shown in Figure 5. Infection with either BRD509 or

GIDIFN strain resulted in similar bacterial growth kinetics in the target organs (liver
and spleen) in both WT and MyD88-/- mice, except for the significantly lower
GIDIFN loads observed at all-time points. In WT mice, the number of GIDIFN
CFUs was 3x and 9.5x fold lower than BRD509E at days 7 and 14 post infection
(Fig. 5A-B). Strikingly, bacterial loads in MyD88-/- mice were significantly increased
compared to their wild-type counterparts (Fig. 5C-D). As early as day 3 post
infection, the bacterial load, of either strain, recovered from MyD88-/- spleens or
livers was >7-fold or ~17-fold higher than that seen in infected wild-type mice. The
significant increase in bacterial proliferation in MyD88-/- mice so early after infection
suggests that a defective early innate immune response may be responsible. By day
14 post infection, the bacterial CFUs of the BRD509E strain in MyD88-/- mice
reached septic levels, with approximately 1 x 108 CFUs/spleen and more than 2 x 107
CFUs/gram of liver. This underlies the higher mortality rate among BRD509Einjected MyD88-/- mice that began to be manifested by 3-4 weeks post infection (Fig.
4). Importantly, even in a background of significant immunodeficiency, the extent of
proliferation observed with the GIDIFN strain in MyD88-/- mice was significantly
lower than that of BRD509E, remaining mostly below septic threshold levels. It
appears, therefore, that the expression of IFN- by Salmonella facilitates their more
efficient elimination, thereby leading to a decrease in host mortality. Similar findings
were found when bacterial loads were compared in infected WT vs. IFN-/- mice
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(Fig. 6). In contrast to WT mice that controlled the infection and had very low
bacterial loads in the liver (<1 CFU/mg), IFN-/- mice exhibited 94-, 1900-, and
78,500-fold higher BRD509E CFUs at 7, 10 and 14 days post infection, respectively.
Despite the heightened susceptibility of IFN-/- mice, bacterial liver CFUs of
GIDIFN were significantly lower (1.7 to 3.7-fold) than the corresponding BRD509E
loads. Thus, the enhanced survival of GIDIFN-infected mice correlates with
decreased bacterial burden in systemic organs.

Figure 5: Rapid clearance of IFN-expressing Salmonella in vivo.
WT (A-B) and MyD88-/- (C-D) mice were inoculated i.p with ~0.5x 106
CFUs/mouse and at indicated time points were sacrificed and the bacterial load
in spleens (A/C) and livers (B/D) enumerated. Each data point represents the
mean ± SEM of 8-15 mice per group. Asterisks denote statistically significant
differences between BRD509E and GIDIFN-infected mice (*p ≤0.05, **p
≤0.01, ***p ≤0.0001).
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Figure 6: Decreased bacterial load of IFN-expressing Salmonella in vivo.
WT (A) and IFN-/- (B) mice were inoculated i.p with ~300 CFUs/mouse and at
indicated time points were sacrificed and bacterial load in livers enumerated.
Each data point represents the mean ± SEM of 3-6 mice per group. Asterisks
denote statistically significant differences between BRD509E and GIDIFN
infected mice (*p < 0.05; **p < 0.01; ***p < 0.001). Compiled from 4
independent experiments.

3.3. Induction of splenomegaly
The degree of splenomegaly induced by infection with BRD509E or GIDIFN
in different mouse strains was assessed. The data for MyD88-/- vs. WT mice
comparison is shown in Figure 7. In both mouse strains, maximum splenomegaly
was observed on day 14 post infection. Despite the fact that the degree of
splenomegaly was relatively greater in MyD88-/- mice, there was a delay in the
induction of this response early in infection. This is seen when one examines
splenomegaly induced on day 3 post infection in both mouse strains. While the mean
spleen weight of infected mice increased by 2.5 to 3.0-fold in WT mice, the mean
weights in MyD88-/- mice represented about 1.6-fold compared to non-infected
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animals. Another consistent observation was that the degree of splenomegaly
induced by GIDIFN was uniformly less than that induced by the BRD509E strain
(Fig. 7A-B). This may well be related to the above-discussed differences in bacterial
loads in target organs, including the spleen.

Figure 7: Infection-induced splenomegaly in Salmonella-injected mice.
Animal were inoculated with ~0.5 x 106 CFUs/mouse of BRD509E or GIDIFN
strain. At days 3, 7 and 14, spleens were aseptically removed WT (A) and
MyD88-/- (B) mice and weighted. Each data point represents the mean ± SEM of
5 mice per group. Asterisks denote statistically significant differences between
BRD509E and GIDIFN infected mice (*p < 0.05; **p < 0.01; ***p < 0.001).

A similar picture could be observed when we compared splenomegaly in
infected WT vs. IFN-/- mice (Fig. 8A-B). In contrast to WT mice that had a
controlled level of splenomegaly, BRD509-infected IFN-/- mice exhibited 1.3- and
2.5-fold higher splenomegaly at 10 and 14 days post infection, respectively. A
similar pattern of splenomegaly was observed in GIDIFN-infected IFN-/- mice;
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however, the extent of the increased spleen weights was in general lower (~10%)
than in BRD509E-infected mice.

Figure 8: Infection-induced splenomegaly in Salmonella-injected mice.
Animal were inoculated with ~300 CFUs/mouse of BRD509E or GIDIFN strain.
At days 7, 10 and 14, spleens were aseptically removed from WT (A) and IFN-/(B) mice and weighted. Each data point represents the mean ± SEM of 3-6 mice
per group. Compiled from 4 independent experiments. Asterisks denote
statistically significant differences between BRD509E and GIDIFN infected
mice (*p < 0.05; **p < 0.01; ***p < 0.001).

3.4. Enumeration of peritoneal cavity cellularity
Recruitment of inflammatory cells was investigated through enumeration of
peritoneal cells harvested from WT and IFN-/- mice following infection with
BRD509E or GIDIFN as shown in Figure 9. Infection with BRD509E results in
recruitment of inflammatory cells at similar levels in both mouse strains (Fig. 9A-B).
Interestingly, infection with GIDIFN causes influx in peritoneal cells as early as 20
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hours post infection, that continues to increase in IFN-/- mice while it normalizes in
WT after 48 hours post infection (Fig. 9A-B). Thus, the expression of IFN- by
GIDIFN correlates with the enhancement in the cellularity of peritoneal cells.

Figure 9: GIDIFN enhances the recruitment of peritoneal cells.
(A-B) WT and IFN-/- mice were infected i.p with 1x106 CFUs/mouse of
BRD509E (A) or GIDIFN (B), and the number of total peritoneal exudate
cells (PEC) was enumerated at indicated time points. Each data point
represents the mean ± SEM of 3-5 mice per group.
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3.5. Phenotypic analysis of recruited cells in the peritoneal cavity post
inoculation with Salmonella
The ratios of different cell sub-populations in the peritoneal cavity 4 and 48
hours after infection with either BRD509E or GIDIFN were next analyzed.
Peritoneal exudate cells from saline-injected mice were used as control. Specifically,
the aim was to ascertain if there were any changes in cell composition in the two
groups of infected animals as compared to control. Moreover, the extent and makeup
of the inflammatory cell infiltrates into the peritoneal cavity was determined. The
results of this analysis are shown in Figures 10-11.
Flow cytometric analysis using PE-cy7-conjugated CD19, APC-cy7conjugated CD11b and PE-conjugated Gr1 mAbs is shown in Figures 10-11. In
uninfected WT mice, four populations were observed; 20% CD19+ CD11b+ (B1
cells) and 62% CD19- CD11b+ (myeloid cells), which represents myeloid cells that is
sub-divided according to the expression of Gr1 surface antigen into: 26% Gr1+
CD11b+ (granulocytes) and 36% Gr1- CD11b+ (macrophages) (Fig. 10A/D).
Upon infection with BRD509, the ratio of myeloid cells increases slightly
(62% to 68%) at 4 hours, then increases to 92% 48 hours post-infection (Fig. 10G).
The increase in myeloid cells observed with BRD509E, is presented by the same
increase of the myeloid sub-populations, with a high increase after 48 hours post
infection (Fig. 10H-I). Moreover, the increase of myeloid cells in infected mice,
corresponds with decease in the ratio of B1 cells that is 6.7- 4.7- fold decrease 48
hours post-infection with BRD509E or GIDIFN, respectively (Fig. 10J). Similar
findings were observed with GIDIFN (Fig. 10H-J). By contrast, in uninfected IFN-/mice, the ratio of myeloid cells is 1.7- fold less than WT, with most of myeloid cells
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comprise of macrophages (35%) compared to the granulocytes (1%), while the ratio
of B1 cells remains similar (19%) (Fig. 11A/D). upon infection with BRD509E, the
ratio of myeloid cells increases to 60% 4 hours post-infection, and remains at similar
ration after 48 hours of infection (Fig. 11G). This increase, is mostly in the
granulocytes with the ratio getting to 26%, then drops to 5.3% after 4 and 48 hours
post-infection, respectively (Fig. 11H). While the ratio of macrophages remains the
same in both infection time points (Fig. 11I). Interestingly, the ratio of myeloid cells
shows 1.5- fold increase in GIDIFN-infected mice compared to BRD509 48 hours
post infection. This increase is marked by the granulocytes, that is 50-fold and 9.3fold higher than uninfected and BRD509E-infected mice, respectively (Fig. 11G-I).
Moreover, infection with either strains causes a decrease in the B1 cell ratios 48
hours post-infection, that is least in GIDIFN-infected mice (19% to 10% and 19% to
3.5%) (Fig. 11G).

Peritoneal cells were prepared from non-infected (A, D), BRD509E-infected (B, E) or GIDIFN-infected (C, F) WT mice
(bacterial dose =1x106 CFUs/mouse). PECs were harvested 4 and 48 hours post inoculation and analyzed using mAbs
specific for CD19, CD11b and Gr1 proteins. The results of analysis of 3 mice per group are shown as cell percentages (panels
G-J) or absolute cell counts (panels K-N). Asterisks denote statistically significant differences between BRD509E and
GIDIFN infected mice (*p < 0.05; **p < 0.01; ***p < 0.001).

Figure 10: Flow cytometric analysis of peritoneal cells post i.p. Salmonella infection in WT mice.
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Peritoneal cells were prepared from non-infected (A, D), BRD509E-infected (B, E) or GIDIFN-infected (C, F) WT mice (bacterial
dose =1x106 CFUs/mouse). PECs were harvested 4 and 48 hours post inoculation and analyzed using mAbs specific for CD19,
CD11b and Gr1 proteins. The results of analysis of 3 mice per group are shown as cell percentages (panels G-J) or absolute cell
counts (panels K Asterisks denote statistically significant differences between BRD509E and GIDIFN infected mice (*p < 0.05; **p
< 0.01; ***p < 0.001).

Figure 11: Flow cytometric analysis of peritoneal cells post i.p. Salmonella infection in IFN-/- mice.
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3.6. Phenotypic analysis of cell populations in the spleen of Salmonella infected
mice
We further assessed the ratios of different cell sub-populations in systemic
organ (spleen) 7 days after infection with BRD509E or GIDIFN. As in the above,
spleen cells from saline-injected mice were used as control, and analysis was based
on comparing the changes of cell composition in the two groups of infected mice to
control mice. The results of this analysis are shown in Figures 13-14.
Flow cytometric analysis using FITC-conjugated CD3, PE-cy7-conjugated
CD19, APC-cy7-conjugated CD11b and PE-conjugated Gr1 mAbs is shown in
Figures 13-14. In uninfected WT mice, cells comprising the spleen were identified
as follows; 50% CD19+ (B cells), 30% CD3+ (T cells) and 12% CD19- CD3(myeloid cells) (Fig. 13A). Myeloid cells sub-populations are identified by their
surface expression of Gr1 into: 4.4% Gr1+ CD11b+ (granulocytes) and 7.6% Gr1CD11b+ (macrophages) (Fig. 13D). Upon infection with BRD509E, the ratio of
myeloid cells increases 2.6-fold, with almost similar increase in the ratios of
granulocytes and macrophages (3.2-fold and 2.2-fold, respectively) compared to
uninfected mice (Fig. 13G-H). Similar findings were observed in GIDIFN-infected
mice, in the matter of fold increase to uninfected and compared to BRD509E (Fig.
13G-H). Infection with BRD509E or GIDIFN cause a 1.3-fold decrease in the ratio
of B cells compared to uninfected mice (Fig. 13J). Similarities in the cell ratios
observed were correlated to the spleen weight and absolute count values (Fig. 12AB).
Data obtained from IFN-/- mice showed similar findings, in the matter of cell
ratios to uninfected mice and between the two bacterial strains (Fig. 14G-I).
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Nevertheless, GIDIFN-infected mice showed a 1.3-fold increase in the ratio of
granulocytes compared to BRD509E (Fig. 14H). Finally, comparison of the absolute
cell counts between the WT and IFN-/-, shows similarities in all cells, except for B
cells which is 1.5-fold more in WT than IFN-\- (Fig. 13K-N & Fig. 14K-N), which
correlates with the higher total spleen cell counts in WT than IFN-\- mice (Fig. 12AB).

Figure 12: Infection induced splenomegaly in Salmonella-injected WT and IFN-/mice.
Animals were inoculated with ~1x106 CFUs/mouse of BRD509E or GIDIFN
strain, and spleens were aspectically removed at day 7 post infection. Data
presented as spleen weights and absolute splenocyte count for WT (panels A-B)
and IFN-/- (panels C-D). Each data point represents the mean ± SEM of 3-4 mice
per group. Asterisks denote statistically significant differences between BRD509E and
GIDIFN infected mice (*p < 0.05; **p < 0.01; ***p < 0.001).

Splenocytes were prepared from non-infected (A, D) or BRD509E-infected (B, E) or GIDIFN-infected (C, F) WT mice. ~1x106
CFUs/mouse was inoculated i.p and spleens were harvested after 7 days. Cells were analyzed using mAbs specific to CD3,
CD19, CD11b and Gr1 proteins and compared to saline group in the form of percentage of total cells (panels G-J) or absolute
count (panels K-N). Each data point represents the mean ± SEM of 3-6 mice per group Asterisks denote statistically significant
differences between BRD509E and GIDIFN infected mice (*p < 0.05; **p < 0.01; ***p < 0.001).

Figure 13: Flow cytometric analysis of spleen cells post Salmonella infection in WT mice.
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Splenocytes were prepared from non-infected (A, D) or BRD509E-infected (B, E)or GIDIFN-infected (C, F) IFN-/mice. 1x106 CFUs/mouse was inoculated i.p and spleens were harvested after 7 days. Cells were analyzed using
mAbs specific to CD3, CD19, CD11b and Gr1 proteins and compared to saline group in the form of percentage of
total cells (panels G-J) or absolute count (panels K-N). Each data point represents the mean ± SEM of 3-6 mice per
group. Asterisks denote statistically significant differences between BRD509E and GIDIFN infected mice (*p <
0.05; **p < 0.01; ***p < 0.001).

Figure 14: Flow cytometric analysis of spleen cells post Salmonella infection in IFN-/- mice.
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3.7. Antimicrobial effect of GIDIFN on ex vivo-cultured peritoneal exudate cells
We assessed the activation status of macrophages in response to Salmonella
infection. Nitric oxide (NO) is an essential anti-microbial compound produced by
activated macrophages in response to Salmonella infection. Thioglycolate-elicited
peritoneal exudate cells were harvested from WT and IFN-/- mice and cultured with
BRD509E or GIDIFN organisms, as described in methods section. Four hours after
initiation of culture, cell-free supernatants were collected and analyzed for NO
content by the Griess assay. As shown in Figure 15, the extent of NO production
was dependent on the bacterial dose used in culture, judging by the increased NO
response as the multiplicity of infection (MOI) increases. WT mice infected with
BRD509E shows increasing level of NO response of 5.6mM, 8.2mM and 54.9mM
corresponding to 5:1, 30:1 and 60:1 MOI, respectively (Fig. 15A). The response
elicited by GIDIFN Salmonella strain was superior to with BRD509E, with 1.9-fold
and 1.3-fold increase in 30:1 and 60:1 MOI, respectively (Fig. 15A). By contrast, NO
response in IFN-/- mice shows similar trend in the increased level in correspondence
to MOI, with GIDIFN Salmonella strain showing superiority in level of NO response
observed as a 1.8-fold and 2-fold increase compared to BRD509 at 30:1 and 60:1
MOI, respectively (Fig. 15B).
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Figure 15: Enhanced production of NO from PECs infected ex-vivo by GIDIFN.
Thioglycolate elucidated PEC were harvested from WT (A) and IFN-/- (B) and
infected for 1 hour with BRD509E or GIDIFN in antibiotic-free medium at
different MOI. At the end of the infection period, non-internalized bacteria were
killed with gentamicin, and cells were further incubated for 4 hours, after which
cell-free culture supernatants were collected and analyzed for nitrite content using
the Greiss method. Each data point represents the mean ± SEM of the
supernatants of 5 ex vivo independent experiments. One way ANOVA was used
to calculate statistical difference.

Finally, we compared the gene expression profiles of cells from the above exvivo experiment in the expression of NO gene regulator (iNOS) and S100A9 (an
early inflammatory marker). Data of fold change and relative expression of WT and
IFN-/- mice are shown in Figure 16. Starting with iNOS, BRD509E-infected WT
cells, shows a minor increase in the expression of iNOS presented as 1.25-fold
increase compared to saline-treated group (Fig. 16A/C). On the other hand, GIDIFNinfected cells, shows superiority with 8.8-fold and 7-fold increase compared to
uninfected and BRD509E-infected cells, respectively (Fig. 16A/C). Remarkably, the
expression of iNOS in IFN-/- mice is much higher than WT, with 15.7-fold and 73.7fold higher gene expression in BRD509E and GIDIFN infected cells, respectively

51

(Fig. 16E/G). In addition, GIDIFN infected to IFN-/- mice, express iNOS 648.6-fold
higher than control, and 33.1-fold higher than BRD509E-infected cells of the same
mouse strain (Fig. 16E/G).
Next, S100A9 gene expression of WT cells shows high level of expression in
response to Salmonella infection, presented as 25.4-fold and 34.3-fold increase of
BRD509E and GIDIFN, respectively as compared to control. Moreover, GIDIFN
express the gene 1.3-fold higher than BRD509E (Fig. 16B/D). By contrast, IFN-/cells expressed the S100A9 gene in a similar trend as in the WT when compared to
control, with the exception of GIDIFN expressing the gene 0.5-fold lower than
BRD509E (Fig. 16F/H). Interestingly, the expression of S100A9 by WT is far more
than IFN-/-, which could suggest that expression of this gene is impaired in the
absence of IFN- (Fig. 16B/D; F/H)
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Figure 16: Enhanced antimicrobial gene expression of GIDIFN infected cells.
Thioglycolate elucidated PEC were harvested from WT (A-D) and IFN-/- (E-H)
and infected for 1 hour with BRD509E or GIDIFN in antibiotic-free medium at
5:1 MOI. At the end of the infection period, non-internalized bacteria were
killed with gentamicin, and cells were further incubated for 4 hours. Cells were
analyzed for their gene expression by RT-PCR for iNOS and S100A9. Data is
presented as fold change compared to the non-infected sample for the WT on the
left panel (A-B) and IFN-/- on the right panel (E-F), or as relative expression of
mRNA of WT (C-D) and IFN-/- (G-H). Each data represents the gene
expression of one experiment.
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Chapter 4: Discussion
Our lab has previously demonstrated the immune-potentiating properties of
GIDIFN, a recombinant derivative of the attenuated aroA/aroD double auxotrophic
mutant BRD509E, which has been engineered to express murine IFN- under the
control of nirB promoter (al-Ramadi et al., 2001). Recently, GIDIFN was shown to
be a more efficient vaccine candidate in two different immunodeficient mouse
models, the C3H/HeJ (TLR4-/- Nramp1R) and CD154-/- (TLR4+/+ Nramp1S) mice (AlOjali et al., 2013; Al-Ojali et al., 2012).
In the present study, IFN-expression by an attenuated Salmonella strain,
GIDIFN, was able to modulate the immune response of two hypersusceptible mouse
strains, MyD88-deficient (MyD88-/-) and IFN--deficient (IFN-/-) mice. This
provides support for the notion that cytokine-expressing, vaccine, strains of
Salmonella may be more amenable for use in immunodeficient hosts in comparison
with the parental, non-cytokine-expressing strain.

4.1. IFN- expression by GIDIFN enhances the survival of extremely susceptible
IFN-/- mice

Salmonella is a facultative intracellular pathogen that causes systemic typhoid
infection. Virulence of these organisms is linked to their capacity to penetrate the
intestinal epithelium and target the phagocytic cells as its replication niche inside a
compartment called Salmonella containing vacuole (SCV) (Chakravortty, 2002).
Controlling bacterial replication at this stage is a decisive factor in determining the
susceptibility of the host to Salmonella infection. This is in part controlled by the
Nramp1 gene, an innate resistance trait for Salmonella infection (Gruenheid & Gros,
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2000; Lang et al., 1997). Nramp1 is essential in resistance to salmonella infection
through the enhancement of phagocytic cell recruitment and phagocytosis process of
intracellular pathogen (Soo et al., 1998). Hosts with mutated Nramp1 as, in the case
of C57BL/6 mice, are considered susceptible to Salmonella due to the reduced
macrophage killing efficacy (Govoni et al., 1999).
Immunity to Salmonella is accomplished through a robust Th1 response, that
is mainly dependent on IFN-, that would regulate the other components of the
immune system to clear the infection (Shtrichman & Samuel, 2001; al-Ramadi et al.,
2006). The role of IFN- in susceptibility to Salmonella was first demonstrated in a
study in which depletion of IFN by a specific mAb resulted in increased
susceptibility of naturally resistant mice, with bacteria proliferating systemically and
mice succumbing to infection after a week of infection (Nauciel & Espinasse-Maes,
1992). Furthermore, Bao and colleagues demonstrated the susceptibility of IFN-
deficient mice in an oral infection model using 5 x 108 CFUs of BRD509E strain,
which resulted in disseminated septicemia two weeks later (Bao et al., 2000).
In the current study, IFN- deficient mice were tested for their differential
susceptibility to BRD509E and GIDIFN strain. Our results show that mice infected
with a very low dose of 300 CFUs/mouse via the i.p. route succumb to the infection
by day 28 post inoculation. These results emphasize the role of IFN- in immunity to
attenuated Salmonella. Accordingly, we hypothesized that IFN--expression by the
recombinant GIDIFN strain could compensate for the lack of IFN- and induce a
better immune response in IFN- deficient hosts.
Compared to BRD509E, GIDIFN strain significantly enhanced the survival
of IFN--deficient mice infected i.p with the same dose. Susceptibility of IFN--
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deficient mice to BRD509E is associated with a loss of bacterial control in target
organs. As shown here, even at a dose of 300 CFUs/mouse, the bacterial burden in
the liver of IFN--deficient mice was 94-, 1900-and 78,500-fold higher than WT
mice at 7, 10 and 14 days post infection, respectively. Although the expression of
IFN- by GIDIFN was not enough to provide the same level of bacterial control as in
WT mice, it nevertheless resulted in a significantly reduced bacterial burden in the
liver compared to the BRD509E strain that was observed at early time points
following infection. This is consistent with early identification of IFN- as a key
regulator of innate immunity to Salmonella infection (Hess et al., 1996).
The effect of GIDIFN on susceptibility of MyD88-deficient mice was also
investigated. Many studies have shown the susceptibility of these mice to bacterial
and viral infections (Scanga et al., 2002; Lund et al., 2003). Furthermore, mice
lacking MyD88 are highly susceptible to attenuated strains of S. typhimurium due to
their inability to control systemic bacterial spread and growth in target organs,
accompanied with delayed recruitment of phagocytic cells, and defective cytokine
production (Issac et al., 2013; al-Ramadi et al., 2004).
As an adaptor molecule for the signaling pathways of most TLRs and other
proinflammatory cytokines, such as IL-2 and IL-18, MyD88 has a great impact in the
initiation of anti-Salmonella immune response through the production of these
proinflammatory cytokines (Raupach et al., 2006). MyD88-/- mice exhibited
increased susceptibility to attenuated Salmonella, with an overall survival rate of
only 30% when given a low dose of 103 CFUs/mouse i.p. In sharp contrast, infection
with GIDIFN resulted in a significant enhancement with ~90% of the infected
animals surviving a similar dose infection. The enhancement in survival was
associated with better control of bacterial replication in target organs.
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A comparison of host susceptibility in the two immunodeficient mouse
models clearly shows that IFN--/- mice are far more susceptible than MyD88-/counterparts. Infection of IFN--/- mice with a dose that was 3 fold lower than the
lowest dose used in MyD88-/- mice (300 vs. 1000 CFUs/mouse) still resulted in
earlier and more pronounced mortality in the former mouse strain. The fact that
GIDIFN could enhance the survival of these extremely susceptible animals is an
indication of the potential significance of this strategy to boost anti-bacterial
immunity in susceptible hosts.

4.2. GIDIFN enhances the recruitment of peritoneal myeloid cells

Early recognition of a pathogen is the first stage of the early innate immune
response. In the case of Salmonella infection, phagocytes can sense the presence of
Salmonella through the recognition by TLRs of Salmonella-associated PAMPs,
including lipopolysaccharide (by TLR4), bacterial lipoproteins (TLR2), flagellin
(TLR5) and CPG DNA (TLR9) (Knapp, 2010). Activation of TLRs leads to the
production of proinflammatory cytokines such as TNF-, IL-6 and IL-12 in a
MyD88-dependent manner through the activation of transcription factor NF-B
(Akira & Takeda, 2004).
Phagocytic cells, including macrophages, neutrophils and dendritic cells, are
crucial during the early stage of an infection for the control of bacterial growth and
recruitment of other immune cells by production of cytokines and chemokines.
Cytokines such as IL-12 mediates immunity to Salmonella through the induction of
IFN- production by NK cells and facilitates the development of a Th1 response
(Castro et al., 1995; Manetti et al., 1993).
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Flow cytometric analysis of peritoneal cells collected at 4 hr or 48 hr after
infection with BRD509E or GIDIFN Salmonella strain revealed the superior capacity
of GIDIFN to recruit myeloid inflammatory cells. This was particularly observed by
the sustained increase in these cells at 48 hr post inoculation. Previous studies have
ascribed a role for IFN- in controlling neutrophil influx through regulating the
chemokine secretion in response to microbial triggers as well as modulating the
expression of chemokine receptors (Robson et al., 2001; Bonecchi et al., 1999). In
our study, hypersusceptibility of IFN--/- mice to Salmonella infection could be partly
due to defective recruitment of inflammatory cells. This is consistent with a study in
which a defect in IFN- impaired neutrophil recruitment, which was restored upon
treatment with recombinant IFN- through normalization of PMN-activating CXC
chemokine expression (McLoughlin et al., 2003).
A comparison of the phenotypic changes at later time points in a systemic
organ (spleen) between BRD509E or GIDIFN-infected WT and IFN--/- mice
surprisingly shows no difference in the extent of myeloid cell recruitment induced by
either bacterial strain, suggesting that the observed GIDIFN-mediated enhancement
is most likely due to its effect at the early phase of infection.

4.3. GIDIFN enhances the anti-microbial effector functions of macrophages

Salmonella is an intra-macrophage pathogen and elimination of such a
microbe requires the activation of bacteria-infected macrophages through IFN-. This
activation induces the bactericidal process through the production of nitric oxide
(NO) and reactive oxygen radicals resulting in increased access of the lytic effector
molecules to the salmonella containing vacuole (Richter-Dahlfors et al., 1997). In
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addition, IFN- enhances antigen presentation via MHC class II and stimulate NK
cells to produce more IFN- and NO via IL-12 production (Liew, 1995). Nitric oxide
has an important role in the killing process of different microbes. Liew and his group
demonstrated the effect of IFN- activated macrophages in killing intracellular
leishmania parasites by NO, which could be inhibited through the addition of a
compound (L-NMMA) which is an antagonist for the L-arginine necessary for the
NO production pathway (Liew et al., 1990). Another study have shown the effect of
neutralizing IL-12 in the dissemination of Salmonella to target organs, due to
reduced level of serum IFN- and downregulation of MHC class II and iNOS (Nitric
oxide synthase), all of which reversed upon treatment with recombinant IFN-
(Mastroeni et al., 1998).
In the present study, co-culture of GIDIFN with PECs induced an
enhancement in the level of NO and upregulated iNOS gene expression. In fact, coculture of WT PECs with BRD509E at MOI of 5:1 for 1 hr failed to increase iNOS
gene expression to any significant level above control. However, when GIDIFN was
used at the same culture conditions, there was a dramatic 7-fold increase in iNOS
expression. Similar findings were observed when IFN-/- PECs were used, with
GIDIFN strain enhancing iNOS expression by 30-fold over the level seen in cells
cultured with BRD509E strain. Together with previous studies, these findings
suggest that IFN- expression by GIDIFN enhances the ability to activate effector
macrophages even in IFN-/- mice. These findings are consistent with previous data
from our laboratory that reported the effect of GIDIFN on peritoneal cells harvested
from thioglycolate-injected BALB/c mice. The capacity of GIDIFN to induce
macrophage activation as evidenced by upregulated expression of macrophage
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activation markers, strong induction of proinflammatory cytokines including, TNF, IL-6 and IL-12 and increased production of antimicrobial effector molecules,
including NO (Fernandez-Cabezudo et al., 2009).
Another marker used to assess macrophage activation is S100A9, which is a
protein expressed on phagocytes that first infiltrate inflammatory sites (Nacken et al.,
2003). S100A9 has an important role in neutrophil recruitment in response to LPS
stimulation (Vandal et al., 2003). S100A9 is an important recognition molecule of
endogenous danger signals in phagocytes and regulates myeloid cell function by
binding to TLR-4 (Vogl et al., 2007; Ehrchen et al., 2009). S100A9 dimerizes with
S100A8 to form a complex (known as calprotectin), which is found predominantly in
myeloid cells, and is actively secreted in response to stress in phagocytic cells
(Markowitz et al., 2013). In one study, S100A9 was reported to act as an inducer of
nitric oxide production by murine macrophages in iNOS-dependent manner (Pouliot
et al., 2008).

In addition, this study showed that S100A9 and IFN- have a

synergistic effect on nitric oxide generation, suggesting an important role of S100A9
in cytokine-mediated activation of phagocytes during the innate immune response
and its effect on modulating antimicrobial functions (Pouliot et al., 2008).
Analysis of S100A9 gene expression in BRD509E- vs. GIDIFN-treated PECs
yielded a different picture. In this case, expression of S100A9 was predominantly
induced by co-culture of PECs with BRD509E bacteria, resulting in 25- and 30-fold
increase over control in WT and IFN-/- PECs, respectively. Similar cultures with the
GIDIFN bacterial strain showed either a modest increase (~1.3-fold in WT) or
decrease (~1.7-fold in IFN-/-) compared to BRD509E. These data demonstrate the
co-requirement for TLR-mediated signaling and IFN- in the optimal activation of
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iNOS. In contrast, S100A9 induction appears to be dependent on TLR signals but
mostly independent of IFN-.
In summary, this study demonstrated the capacity of a genetically-engineered,
IFN-expressing Salmonella strain (GIDIFN) to significantly enhance the survival of
two immunodeficient, Salmonella-hypersusceptible mouse strains, namely MyD88-/and IFN--/- mice. This enhancement was correlated with decreased bacterial loads in
systemic organs, possibly due to the enhanced ability of GIDIFN to activate effector
macrophages, as shown by increased synthesis of anti-microbial effector molecules,
including NO. These findings suggest the potential use of attenuated bacterial strains
expressing immunomodulatory genes as a therapeutic approach in immunodeficient
hosts.
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